ImageneBio (IMA) Profit After Tax (2020 - 2025)

ImageneBio has reported Profit After Tax for 6 years, with the latest figure at -$25.6 million in Q3 2025.

• Quarterly Profit After Tax fell 314.58% year-over-year to -$25.6 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$51.1 million (up 5.87% YoY) and the FY2024 annual result came in at -$49.2 million, up 27.77% from the prior year.
• Profit After Tax slipped to -$25.6 million in Q3 2025 per IMA's latest filing, from -$7.6 million in the prior quarter.
• Over five years, Profit After Tax peaked at $2.8 million in Q4 2021 and troughed at -$25.6 million in Q3 2025.
• A 5-year average of -$13.6 million and a median of -$14.5 million in 2021 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2021 and 2022: Profit After Tax surged 110.74% in 2021, then sank 631.28% in 2022.
• Over 5 years, Profit After Tax stood at $2.8 million in 2021, then tumbled by 631.28% to -$14.9 million in 2022, then slumped by 31.15% to -$19.5 million in 2023, then jumped by 55.25% to -$8.7 million in 2024, then plunged by 193.83% to -$25.6 million in 2025.
• According to Business Quant data, Profit After Tax over the past three periods registered -$25.6 million, -$7.6 million, and -$9.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.